Identification of interactive loci linked to insulin and leptin in mice with genetic insulin resistance

Diabetes

Volumn 52, Issue 6, 2003, Pages 1535-1543

  Almind, Katrine ^a   Kulkarni, Rohit N ^b   Lannon, Scott M ^b   Kahn, C Ronald ^b  

^a JOSLIN DIABETES CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 1; LEPTIN; UNCOUPLING PROTEIN 2; UNCOUPLING PROTEIN 3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CHROMOSOME 12; CHROMOSOME 14; CHROMOSOME 7; DIABETOGENESIS; DNA MODIFICATION; GENE LOCATION; GENETIC ANALYSIS; GENOME; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SCORING SYSTEM;

ANIMALS; BLOOD GLUCOSE; CROSSES, GENETIC; DIABETES MELLITUS; FEMALE; GENE DELETION; HETEROZYGOTE; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOPROTEINS; RECEPTOR, INSULIN; SPECIES SPECIFICITY;

EID: 0038659916     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.6.1535     Document Type: Article

References (47)

1. Smith C, Falconer DS, Duncan LJ: A statistical and genetical study of diabetes. II. Heritability of liability. Ann Hum Genet 35:281-299, 1972
2. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
3. Kahn CR, Vicent D, Doria A: Genetics of non-insulin-dependent (type II) diabetes mellitus. Annu Rev Med 47:509-531, 1996
4. Poulsen P, Kyvik KO, Vaag A, Beck-Nielsen H: Heritability of type II (non-insulin-dependent) diabetes mellitus and abnormal glucose tolerance: a population-based twin study. Diabetologia 42:139-145, 1999
5. Zimmet PZ: Kelly West Lecture 1991: Challenges in diabetes epidemiology: from West to the rest. Diabetes Care 15:232-252, 1992
6. Almind K, Doria A, Kahn CR: Putting the genes for type II diabetes on the map. Nat Med 7:277-279, 2001
7. Fajans SS, Bell GI, Polonsky KS: Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 345:971-980, 2001
8. Maassen JA, Jansen JJ, Kadowaki T, van den Ouweland JM, Hart LM, Lemkes HH: The molecular basis and clinical characteristics of maternally inherited diabetes and deafness (MIDD), a recently recognized diabetic subtype. Exp Clin Endocrinol Diabetes 104:205-211, 1996
9. Flier JS: Lilly Lecture: Syndromes of insulin resistance: from patient to gene and back again. Diabetes 41:1207-1219, 1992
10. Leiter EH: Mice with targeted gene disruptions or gene insertions for diabetes research: problems, pitfalls, and potential solutions. Diabetologia 45:296-308, 2002
11. Bruning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR: Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles. Cell 88:561-572, 1997
12. a. Kulkarni RN, Almind K, Goren HJ, Winnay JN, Ueki K, Okada T, Kahn CR: Impact of genetic background on development hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 52:1528-1534, 2003
13. Manly K, Olson JM: Overview of qtl mapping software and introduction to map manager qt. Mamm Genome 10:327-334, 1999
14. Lander ES, Green P, Abrahamson J, Barlow A, Daly MJ, Lincoln SE, Newburg L: MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics 1:174-181, 1987
15. Lincoln S, Daly M, Lander ES: Mapping Genes Controlling Quantitative Traits. Whitehead Institute for Biomedical Research Technical Report, Second Ed., January 1993 (Beta Distribution 38)
16. Paterson AH, Lander ES, Hewitt JD, Peterson S, Lincoln SE, Tanksley SD: Resolution of quantitative traits into mendelian factors by using a complete linkage map of restriction fragment length polymorphism. Nature 335:721-726, 1998
17. Weller EA, Ryan LM: Testing for trend with count data. Biometr 54:762-773, 1998
18. Mahrer JM, Magel RC: A comparison of tests for the k-sample, nondecreasing alternative. Stat Med 14:863-871, 1995
19. Araki E, Lipes MA, Patti ME, Bruning JC, Haag BL III, Johnson RS, Kahn CR: Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190, 1994
20. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
21. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF: Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900-904, 1998
22. Fruhbeck G, Salvador J: Regulation between leptin and the regulation of glucose metabolism. Diabetologia 43:3-12, 2000
23. DeFronzo RA: Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview. Diabetologia 35:389-397, 1992
24. Sawka-Verhelle D, Tartare-Deckert S, Decaux JF, Girard J, Van Obberghen E: Stat 5B, activated by insulin in a Jak-independent fashion, plays a role in glucokinase gene transcription. Endocrinology 141:1977-1988, 2000
25. Liu B, Liao J, Rao X, Kushner S, Chung CD, Chang DD, Shuai K: Inhibition of stat1-mediated gene activation by pias1. Proc Natl Acad Sci U S A 95:10626-10631, 1998
26. Huppi K, Siwarski D, Goodnight J, Mischak H: Assignment of the protein kinase c delta polypeptide gene (PRKCD) to human chromosome 3 and mouse chromosome 14. Genomics 19:161-162, 1993
27. Cormont M, Bortoluzzi MN, Gautier N, Mari M, Van Obberghen E, Le Marchand-Brustel Y: Potential role of Rab4 in the regulation of subcellular localization of Glut4 in adipocytes. Mol Cell Biol 16:6879-6886, 1996
28. Camps M, Nichols A, Arkinstall S: Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14:6-16, 2000
29. Kido Y, Philippe N, Schaffer AA, Accili D: Genetic modifiers of the insulin resistance phenotype in mice. Diabetes 49:589-596, 2000
30. Mehrabian M, Wen PZ, Fisler J, Davis RC, Lusis AJ: Genetic loci controlling body fat, lipoprotein metabolism, and insulin levels in a multifactorial mouse model. J Clin Invest 2485-2496, 1998
31. Stoehr JP, Nadler ST, Schueler KL, Rabaglia ME, Yandell BS, Metz SA, Attie AD: Genetic obesity unmasks nonlinear interactions between murine type 2 diabetes susceptibility loci. Diabetes 49:1946-1954, 2000
32. Surwit RS, Wang S, Petro AE, Sanchis D, Raimbault S, Ricquier D, Collins S: Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc Natl Acad Sci U S A 95:4061-4065, 1998
33. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN: Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167, 1988
34. Surwit RS, Petro AE, Parekin P, Collins S: Low plasma leptin in response to dietary fat in diabetes- and obesity-prone mice. Diabetes 46:1516-1520, 1997
35. Watson PM, Commins SP, Beiler RJ, Hatcher HC, Gettys TW: Differential regulation of leptin expression and function in A/J vs. C57B1/6j mice during diet-induced obesity. Am J Physiol Endocrinol Metab 249:E356-E365, 2000
36. Boss O, Hagen T, Lowell BB: Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 49:143-156, 2000
37. Sivitz WI, Fink BD, Donohoue PA: Fasting and leptin modulate adipose and muscle uncoupling protein: divergent effects between messenger ribonucleic acid and protein expression. Endocrinology 140:1511-1519, 1999
38. Scarpace PJ, Nicolson M, Matheny M: UCP2, ucp3 and leptin gene expression: modulation by food restriction and leptin. J Endocrinol 159:349-357, 1998
39. Cusin I, Zakrzewska KE, Boss O, Muzzin P, Giacobino JP, Ricquier D, Jeanrenaud B, Rohner-Jeanrenaud F: Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins. Diabetes 47:1014-1019, 1998
40. Combatsiaris TP, Charron MJ: Downregulation of uncoupling protein 2 mRNA in white adipose tissue and uncoupling protein 3 mRNA in skeletal muscle during the early stages of leptin treatment. Diabetes 48:128-133, 1999
41. Fleury C, Nerova M, Collins S, Raimbault S, Seldin MF, Surwit RS, Ricquier D, Warden CH: Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia. Nat Genet 15:269-272, 1997
42. York B, Truett AA, Monteiro MP, Barry SJ, Warden CH, Naggert JK, Maddatu TP, West DB: Gene-environment interaction: a significant diet-dependent obesity locus demonstrated in a congenic segment on mouse chromosome 7. Mamm Genome 10:457-462, 1999
43. Taylor BA, Philips SJ: Detection of obesity QTLs on mouse chromosomes 1 and 7 by selective DNA pooling. Genomics 34:389-398, 1996
44. Warden CH, Fisler JS, Pace MJ, Svenson KL, Lusis AJ: Coincidence of genetic loci for plasma cholesterol levels and obesity in a multifactorial mouse model. J Clin Invest 92:773-779, 1993
45. Dalgaard LT, Pedersen O: Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and type II diabetes. Diabetologia 44:946-965, 2001
46. Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D: Linkage between markers in the vicinity of the uncoupling protein 2 gene and resting metabolic rate in humans. Hum Mol Genet 6:1887-1889, 1997
47. Schrauwen P, Hesselink MK, Blank EE, Borghouts LB, Schaart G, Saris WH, Keizer HA: Uncoupling protein 3 content is decreased in skeletal muscle of patients with type 2 diabetes. Diabetes 50:2870-2873, 2001